Characterizing and Engineereing Mesenchymal Stem Cells for Antimicrobial Therapy.
Conference
·
OSTI ID:1602946
Abstract not provided.
- Research Organization:
- Sandia National Lab. (SNL-CA), Livermore, CA (United States); Sandia National Lab. (SNL-NM), Albuquerque, NM (United States)
- Sponsoring Organization:
- USDOE National Nuclear Security Administration (NNSA)
- DOE Contract Number:
- AC04-94AL85000
- OSTI ID:
- 1602946
- Report Number(s):
- SAND2019-2167C; 672958
- Resource Relation:
- Conference: Proposed for presentation at the Chemical and Biological Terrorism Defense, Gordon Conference held March 4 - February 8, 2019 in Ventura, CA.
- Country of Publication:
- United States
- Language:
- English
Similar Records
Mesenchymal stem cell-based therapy for infectious disease.
Characterizing and Engineering Mesenchymal Stromal Cells for Anti-Microbial Therapy.
Characterizing and Engineering Mesenchymal Stromal Cells for Anti-Microbial Therapy.
Conference
·
Mon Oct 01 00:00:00 EDT 2018
·
OSTI ID:1602946
+3 more
Characterizing and Engineering Mesenchymal Stromal Cells for Anti-Microbial Therapy.
Conference
·
Sat Jun 01 00:00:00 EDT 2019
·
OSTI ID:1602946
+3 more
Characterizing and Engineering Mesenchymal Stromal Cells for Anti-Microbial Therapy.
Conference
·
Fri Nov 01 00:00:00 EDT 2019
·
OSTI ID:1602946
+3 more